WAVE Life Sciences Ltd.
WVE
$6.99
-$0.42-5.67%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 109.23M | 93.95M | 104.94M | 108.30M | 53.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 109.23M | 93.95M | 104.94M | 108.30M | 53.61M |
| Cost of Revenue | 174.61M | 169.93M | 166.86M | 159.68M | 149.11M |
| Gross Profit | -65.38M | -75.99M | -61.92M | -51.38M | -95.50M |
| SG&A Expenses | 70.57M | 67.52M | 63.83M | 59.02M | 56.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 245.18M | 237.46M | 230.69M | 218.71M | 205.66M |
| Operating Income | -135.95M | -143.51M | -125.75M | -110.40M | -152.05M |
| Income Before Tax | -121.95M | -129.87M | -112.33M | -97.01M | -142.52M |
| Income Tax Expenses | -- | -- | -- | -- | 0.00 |
| Earnings from Continuing Operations | -121.95 | -129.87 | -112.33 | -97.01 | -142.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -121.95M | -129.87M | -112.33M | -97.01M | -142.52M |
| EBIT | -135.95M | -143.51M | -125.75M | -110.40M | -152.05M |
| EBITDA | -132.45M | -139.92M | -122.02M | -106.51M | -147.98M |
| EPS Basic | -0.74 | -0.88 | -0.83 | -0.78 | -1.11 |
| Normalized Basic EPS | -0.46 | -0.55 | -0.52 | -0.49 | -0.70 |
| EPS Diluted | -0.75 | -0.89 | -0.84 | -0.79 | -1.12 |
| Normalized Diluted EPS | -0.47 | -0.56 | -0.52 | -0.50 | -0.70 |
| Average Basic Shares Outstanding | 655.74M | 620.57M | 586.11M | 552.85M | 500.99M |
| Average Diluted Shares Outstanding | 666.54M | 631.37M | 596.91M | 563.65M | 500.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |